Comparison 8. ACE‐I vs CCB.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Total Serious Adverse Events	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 All‐cause mortality	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Non‐fatal cardiovascular events	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Acute Myocardial Infarction	1	20	Risk Ratio (M‐H, Fixed, 95% CI)	0.5 [0.05, 4.67]
4.1 Captopril vs Nifedipine	1	20	Risk Ratio (M‐H, Fixed, 95% CI)	0.5 [0.05, 4.67]
5 Withdrawals due to adverse effects	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Mean change in systolic blood pressure during treatment	4	183	Mean Difference (IV, Fixed, 95% CI)	1.68 [‐1.78, 5.14]
6.1 Captopril vs Nifedipine	4	183	Mean Difference (IV, Fixed, 95% CI)	1.68 [‐1.78, 5.14]
7 Mean change in diastolic blood pressure during treatment	4	183	Mean Difference (IV, Fixed, 95% CI)	7.86 [4.92, 10.81]
7.1 Captopril vs Nifedipine	4	183	Mean Difference (IV, Fixed, 95% CI)	7.86 [4.92, 10.81]
8 Mean change in heart rate during treatment	3	126	Mean Difference (IV, Fixed, 95% CI)	‐15.79 [‐18.00, ‐11.59]
8.1 Captopril vs Nifedipine	3	126	Mean Difference (IV, Fixed, 95% CI)	‐15.79 [‐18.00, ‐11.59]